Cargando…

Lower Body Mass Index at Baseline Is Related to Steeper Cognitive Decline in the Alzheimer’s Disease Neuroimaging Initiative Cohort

OBJECTIVE: Midlife obesity is a risk factor for dementia, whereas obesity in older age may be protective of cognition, a phenomenon known as the “obesity paradox.” The mechanisms underlying this phenomenon and the relationship between body mass index (BMI) and cognitive function over time remain unc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haley, Andreana P., Clark, Alexandra L., Duarte, Audrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662601/ https://www.ncbi.nlm.nih.gov/pubmed/37594246 http://dx.doi.org/10.1097/PSY.0000000000001245

Ejemplares similares

Steeper memory decline after COVID-19 lockdown measures
por: Bakker, Els D., et al.
Publicado: (2023)

Lower Plasma Total Testosterone Levels Were Associated With Steeper Decline in Brain Glucose Metabolism in Non-demented Older Men
por: Wang, Xiwu, et al.
Publicado: (2021)

Women with lower systemic inflammation demonstrate steeper cognitive decline with age: Results from a large prospective, longitudinal sample
por: Noss, Melody Moloci, et al.
Publicado: (2022)

Steeper Change in Body Mass Across Four Decades Predicts Poorer Cardiometabolic Outcomes at Midlife
por: Xian, Hong, et al.
Publicado: (2017)

Learning curve for hip arthroscopy steeper than expected
por: Nawabi, Danyal H., et al.
Publicado: (2016)

Annual decline in forced expiratory volume is steeper in aluminum potroom workers than in workers without exposure to potroom fumes
por: Søyseth, Vidar, et al.
Publicado: (2016)

Age exacerbates the negative effect of depression on executive functioning in racial and ethnic minorities
por: Niu, Zhimei, et al.
Publicado: (2023)

Steeper or Faster? Tactical Dispositions to Minimize Oxygen Cost in Ski Mountaineering
por: Sunde, Arnstein, et al.
Publicado: (2022)

Sex-Specific Association of Lifetime Body Mass Index with Alzheimer’s Disease Neuroimaging Biomarkers
por: Lee, Seung Hoon, et al.
Publicado: (2020)

Baseline Neuroimaging Predicts Decline to Dementia From Amnestic Mild Cognitive Impairment
por: Gullett, Joseph M., et al.
Publicado: (2021)

Steeper Iris Conicity Is Related to a Shallower Anterior Chamber: The Gutenberg Health Study
por: Schuster, Alexander K., et al.
Publicado: (2017)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

Q & A: The Alzheimer's disease neuroimaging initiative
por: Aisen, Paul S
Publicado: (2011)

Body mass index trajectories and associations with cognitive decline in people with Lewy body dementia and Alzheimer's disease
por: Borda, Miguel G., et al.
Publicado: (2022)

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
por: Wang, Xiaoqi, et al.
Publicado: (2020)

Body Mass Index and Decline of Cognitive Function
por: Kim, Sujin, et al.
Publicado: (2016)

BODY MASS INDEX AND COGNITIVE FUNCTION DECLINE
por: Hua, Yingxiao, et al.
Publicado: (2019)

Steeper structure-function relationship in eyes with than without a parapapillary deep-layer microvasculature dropout
por: Kim, Ji-Ah, et al.
Publicado: (2018)

Steeper dose gradients resulting from reduced source to target distance—a planning system independent study
por: Bratengeier, Klaus, et al.
Publicado: (2018)

Multimodal Neuroimaging Predictors of Gait Decline
por: Sargent, Lana, et al.
Publicado: (2020)

Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline
por: Pink, Anna, et al.
Publicado: (2023)

A Meta-analysis of Asbestos and Lung Cancer: Is Better Quality Exposure Assessment Associated with Steeper Slopes of the Exposure–Response Relationships?
por: Lenters, Virissa, et al.
Publicado: (2011)

Adding Recognition Discriminability Index to the Delayed Recall Is Useful to Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative
por: Russo, María J., et al.
Publicado: (2017)

The Influence of Body Mass Index at Diagnosis on Cognitive Decline in Parkinson's Disease
por: Yoo, Han Soo, et al.
Publicado: (2019)

Presumed small vessel disease, imaging and cognition markers in the Alzheimer’s Disease Neuroimaging Initiative
por: Fiford, Cassidy M, et al.
Publicado: (2021)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
por: Gamberger, Dragan, et al.
Publicado: (2016)

Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
por: Canevelli, Marco, et al.
Publicado: (2020)

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
por: Veitch, Dallas P., et al.
Publicado: (2021)

Effects of sex, educational background, and chronic kidney disease grading on longitudinal cognitive and functional decline in patients in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Iwata, Atsushi, et al.
Publicado: (2018)

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
por: Abdullah, Laila, et al.
Publicado: (2020)

Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
por: Wang, Qing, et al.
Publicado: (2022)

Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers
por: Hong, Yun Jeong, et al.
Publicado: (2019)

Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer’s disease neuroimaging initiative
por: Yao, Xiaohui, et al.
Publicado: (2017)

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort
por: Barupal, Dinesh Kumar, et al.
Publicado: (2018)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
por: Weber, Christopher J., et al.
Publicado: (2021)

Lower Baseline Serum Triglyceride Levels Are Associated With Higher Decrease in Body Mass Index After Laparoscopy Sleeve Gastrectomy Among Obese Patients
por: Huang, Xiu, et al.
Publicado: (2021)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis
por: Giles, Jon T, et al.
Publicado: (2021)

Fibromyalgia Syndrome and Cognitive Decline: The Role of Body Mass Index and Clinical Symptoms
por: Muñoz Ladrón de Guevara, Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kvukme1lp7evsrbjkie4ijrn7p